Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II open-label study of oral HX9428 in Chinese patients with wet age-related macular degeneration
CTR20251878Phase 2Active
- Sponsor
- Haixi New Pharma
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HX9428 in exudative macular degeneration, sponsored by Haixi New Pharma. Started May 2025; status: active.
02
Drugs
HX9428
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on CTR20251878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251878.